Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.19 -0.03 (0.29%)
Previous Close $10.22    52 Week High $9.23 
Open $10.10    52 Week Low $1.16 
Day High $10.36    P/E N/A 
Day Low $9.75    EPS $-0.30 
Volume 4,230,498